학술논문
A phase i open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancer
Document Type
Article
Author
Source
In: Investigational New Drugs . (Investigational New Drugs, February 2015, 33(1):138-147)
Subject
Language
English
ISSN
15730646
01676997
01676997